Pharmaceutical Growth Opportunities in the EU Accession States: Healthcare reform, market dynamics and key players

The expansion of the EU has created exciting opportunities for pharmaceutical companies to expand into new territories and take advantage of these high growth emerging markets; this report analyzes eight of the accession countries including the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Slovakia and Slovenia (The A8). Pharmaceutical Growth Opportunities in the EU Accession States is a new report which provides in-depth insights into the competitive dynamics of the EU accession states. It identifies the key drivers and resistors of growth to enable you to understand the most important factors behind success in each country market. Use this latest report to determine key product opportunities, identify potential alliance partners and plan a successful and sustainable long term growth strategy to secure your leading position in the next five years.

Published: May 2006, Pages 199, PDF
Table of Contents
Price: $2,875.00 / GBP1,437.50